Ambrx Biopharma Cayman, Inc. Quarterly Operating Lease, Liability, Current in USD from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q4 2020 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Operating Lease, Liability, Current for the quarter ending June 30, 2023 was $1.85M, a 40.5% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $1.85M +$534K +40.5% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.79M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.73M +$819K +89.5% Dec 31, 2022 10-Q 2023-08-09
Q2 2022 $1.32M Jun 30, 2022 6-K 2022-08-29
Q4 2021 $915K -$680K -42.6% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $1.6M Dec 31, 2020 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.